The association between nonsteroidal anti-inflammatory drugs and potassium concentrations: A pharmacoepidemiological study in Saudi Arabia

被引:0
作者
Aljadhey, Hisham [1 ]
机构
[1] King Saud Univ, Coll Pharm, Medicat Safety Res Chair, Riyadh, Saudi Arabia
关键词
Pharmacoepidemiology; NSAIDs; Potassium; ACUTE-RENAL-FAILURE; ELDERLY PERSONS; HYPERKALEMIA; INHIBITORS; EVENTS; TRIAL; DIET; RISK;
D O I
10.1016/j.jsps.2011.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Several nonsteroidal anti-inflammatory drugs (NSAIDs) have been linked to cardiac death. The mechanism that is responsible for this adverse effect appears to be ischemic insult; however, another possible mechanism involves hyperkalemia. The objective of the present study was to determine the feasibility of conducting pharmacoepidemiological studies in Saudi Arabia using refill prescription data to investigate the association between NSAIDs and increased serum potassium concentrations. Methods: This retrospective cohort study included patients from an academic medical center in Riyadh, Saudi Arabia. The patients who were recently prescribed NSAIDs were compared to a control group of paracetamol users, with respect to the drugs' effects on serum potassium concentrations. The covariates that affected the potassium concentration or the use of NSAIDs were controlled for in the analysis. The studied outcome was the first serum potassium concentration of more than 5 mEq/L. Results: A total of 184 patients were prescribed NSAIDs (n = 101) or paracetamol (n = 83) and met the inclusion criteria. Compared to the control group, the patients who received NSAIDs were more likely to be women, were less likely to use angiotensin-converting enzyme inhibitors, and were more likely to have lower baseline serum creatinine concentrations. The other baseline characteristics were similar between the patients in the NSAID group and the patients who received paracetamol. Compared to the patients who were prescribed paracetamol, those who were prescribed NSAIDs did not have an increased risk of hyperkalemia (odds ratio, 1.1, 95% confidence interval, 0.17-6.7, P = 0.95). Conclusion: In the present, small feasibility study, no increase in the risk of hyperkalemia was associated with NSAIDs compared to paracetamol. The present study was exploratory and included only a small number of patients; therefore, this study may not be sufficiently powered to detect small differences between the groups. Future studies with larger sample sizes are needed to investigate the association between NSAIDs and hyperkalemia. (C) 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 23 条
[1]   Risk of hyperkalemia associated with selective COX-2 inhibitors [J].
Aljadhey, Hisham ;
Tu, Wanzhu ;
Hansen, Richard A. ;
Blalock, Susan ;
Brater, Craig ;
Murray, Michael D. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) :1194-1198
[2]   Developing the Sentinel System - A National Resource for Evidence Development [J].
Behrman, Rachel E. ;
Benner, Joshua S. ;
Brown, Jeffrey S. ;
McClellan, Mark ;
Woodcock, Janet ;
Platt, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) :498-499
[3]   Acute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors [J].
Braden, GL ;
O'Shea, MH ;
Mulhern, JG ;
Germain, MJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1149-1153
[4]   Renal effects of cyclooxygyenase-2-selective inhibitors [J].
Brater, DC .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (04) :S15-S20
[5]   Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].
Bresalier, RS ;
Sandler, RS ;
Quan, H ;
Bolognese, JA ;
Oxenius, B ;
Horgan, K ;
Lines, C ;
Riddell, R ;
Morton, D ;
Lanas, A ;
Konstam, MA ;
Baron, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102
[6]   Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study [J].
Graham, DJ ;
Campen, D ;
Hui, R ;
Spence, M ;
Cheetham, C ;
Levy, G ;
Shoor, S ;
Graham, D .
LANCET, 2005, 365 (9458) :475-481
[7]   KETOROLAC-INDUCED ACUTE-RENAL-FAILURE AND HYPERKALEMIA - REPORT OF 3 CASES [J].
HARAGSIM, L ;
DALAL, R ;
BAGGA, H ;
BASTANI, B .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (04) :578-580
[8]   Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet [J].
Hay, E ;
Derazon, H ;
Bukish, N ;
Katz, L ;
Kruglyakov, I ;
Armoni, M .
JOURNAL OF EMERGENCY MEDICINE, 2002, 22 (04) :349-352
[9]   Identifying adverse drug events: Development of a computer-based monitor and comparison with chart review and stimulated voluntary report [J].
Jha, AK ;
Kuperman, GJ ;
Teich, JM ;
Leape, L ;
Shea, B ;
Rittenberg, E ;
Burdick, E ;
Seger, DL ;
Vander Vliet, M ;
Bates, DW .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1998, 5 (03) :305-314
[10]  
KELLEY M, 1995, CLIN NEPHROL, V44, P276